Skip to content
S7872Senate2023-2024 SessionSame asA8619

Extend Pharmacist Test Authority

Official title

“Extends provisions of law relating to pharmacists”

Sponsor Gustavo RiveraSD-33+3 co-sponsorsAffects Education
Status
In Senate Committee
Rules
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Rules

What's happening

This bill extends the authorization for pharmacists to provide certain testing and collaborative drug therapy management with physicians until July 1, 2026.

Why it matters

  1. Extending pharmacists’ authority to conduct COVID-19 and flu testing, and to manage drug therapy with physicians, maintains expanded healthcare access for New Yorkers—especially important in areas with physician shortages or high demand for testing.

  2. By pushing the expiration date to July 1, 2026, the bill gives state policymakers more time to evaluate the effectiveness and safety of pharmacists’ expanded roles before deciding on permanent changes or further extensions.

  3. Continued authorization for collaborative drug therapy management supports innovative healthcare models that can improve patient outcomes, streamline chronic disease management, and potentially lower healthcare costs by leveraging pharmacists’ expertise.

  4. This extension signals ongoing recognition of pharmacists as critical frontline healthcare providers, which may influence future workforce training, resource allocation, and the evolution of healthcare delivery in New York.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Extend Pharmacist Test Authority

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Gustavo Rivera

Senator · Senate District 33

Chair, Health

History

  1. Committed to rules
  2. Amended on third reading (t) 7872a
  3. Advanced to third reading
  4. 2nd report cal.
  5. 1st report cal.234
  6. Referred to higher education

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A8619Assembly

Extend Pharmacist Authority

Assembly Floor Calendar · Sponsor Amy Paulin

Impact 6 · Moderate0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

7872--A Cal. No. 234

IN SENATE

January 3, 2024

Introduced by Sens. RIVERA, FERNANDEZ, JACKSON, WEIK -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education -- reported favorably from said committee, ordered to first and second report, ordered to a third reading, amended and ordered reprinted, retaining its place in the order of third reading

AN ACT to amend part C of chapter 57 of the laws of 2022 amending the public health law and the education law relating to allowing pharmacists to direct limited service laboratories and order and administer COVID-19 and influenza tests and modernizing nurse practitioners, in relation to the effectiveness thereof; and to amend chapter 21 of the laws of 2011 amending the education law relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings, in relation to the effectiveness thereof

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 8 of part C of chapter 57 of the laws of 2022 amending the public health law and the education law relating to allowing pharmacists to direct limited service laboratories and order and administer COVID-19 and influenza tests and modernizing nurse practitioners, is amended to read as follows:

§ 8. This act shall take effect immediately and shall be deemed to have been in full force and effect on and after April 1, 2022; provided, however, that sections one, two, three, four, six and seven of this act shall expire and be deemed repealed [two years after it shall have become a law] July 1, 2026.

§ 2. Section 5 of chapter 21 of the laws of 2011 amending the education law relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings, as amended by section 5 of part CC of chapter 57 of the laws of 2022, is amended to read as follows:

§ 5. This act shall take effect on the one hundred twentieth day after it shall have become a law, provided, however, that the provisions of sections two, three, and four of this act shall expire and be deemed repealed July 1, [2024] 2026; provided, however, that the amendments to

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD13910-02-4

subdivision 1 of section 6801 of the education law made by section one of this act shall be subject to the expiration and reversion of such subdivision pursuant to section 8 of chapter 563 of the laws of 2008, when upon such date the provisions of section one-a of this act shall take effect; provided, further, that effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.

§ 3. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend part C of chapter 57 of the laws of 2022 amending the public health law and the education law relating to allowing pharmacists to direct limited service laboratories and order and administer COVID-19 and influenza tests and modernizing nurse practitioners, in relation to the effectiveness thereof; and to amend chapter 21 of the laws of 2011 amending the education law relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings, in relation to the effectiveness thereof

PURPOSE::

To extend the provisions of law that: authorize pharmacists to direct limited service laboratories and order and administer COVID-19 and influenza tests; exempt certain nurse practitioners from written prac- tice agreement and written practice protocol requirements; authorize physicians and nurse practitioners to prescribe and order a non-patient specific regimen to registered professional nurses for the adminis- tration of COVID 19 and influenza tests; and authorize pharmacists to perform collaborative drug therapy management with physicians in certain settings.

SUMMARY OF PROVISIONS::

This bill extends, through July 1, 2026, the provisions of law that: authorize pharmacists to direct limited service laboratories and order and administer COVID-19 and influenza tests; exempt certain nurse prac- titioners from written practice agreement and written practice protocol requirements; authorize physicians and nurse practitioners to prescribe and order a non-patient specific regimen to registered professional nurses for the administration of COVID 19 and influenza tests; and authorize pharmacists to perform collaborative drug therapy management with physicians in certain settings.

JUSTIFICATION::

This legislation ensures that pharmacists, registered professional nurs- es, and nurse practitioners can continue providing certain healthcare services without disruption.

LEGISLATIVE HISTORY::

This is new legislation.

FISCAL IMPLICATIONS::

To be determined.

EFFECTIVE DATE::

Immediate.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.